Functional Characterization of the Novel and Specific Thyroid Hormone Transporter SLC17A4

Stefan Groeneweg*, Ferdy S. Van Geest, Zhongli Chen, Stefania Farina, Ramona E.A. Van Heerebeek, Marcel E. Meima, Robin P. Peeters, Heike Heuer, Marco Medici, W. Edward Visser

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)

Abstract

Background: A recent genome-wide association study identified the SLC17A4 locus associated with circulating free thyroxine (T4) concentrations. Human SLC17A4, being widely expressed in the gastrointestinal tract, was characterized as a novel triiodothyronine (T3) and T4 transporter. However, apart from the cellular uptake of T3 and T4, transporter characteristics are currently unknown. In this study, we delineated basic transporter characteristics of this novel thyroid hormone (TH) transporter. Methods: We performed a broad range of well-established TH transport studies in COS-1 cells transiently overexpressing SLC17A4. We studied cellular TH uptake in various incubation buffers, TH efflux, and the inhibitory effects of different TH metabolites and known inhibitors of other TH transporters on SLC17A4-mediated TH transport. Finally, we determined the effect of tunicamycin, a pharmacological inhibitor of N-linked glycosylation, and targeted mutations in Asn residues on SLC17A4 function. Results: SLC17A4 induced the cellular uptake of T3 and T4 by ∼4 times, and of reverse (r)T3 by 1.5 times over control cells. The uptake of T4 by SLC17A4 was Na+ and Cl- independent, stimulated by low extracellular pH, and reduced by various iodothyronines and metabolites thereof, particularly those that contain at least three iodine moieties irrespective of the presence of modification at the alanine side chain. None of the classical TH transporter inhibitors studied attenuated SLC17A4-mediated TH transport. SLC17A4 also facilitates the efflux of T3 and T4, and to a lesser extent of 3,3′-diiodothyronine (T2). Immunoblot studies on lysates of transfected cells cultured in absence or presence of tunicamycin indicated that SLC17A4 is subject to N-linked glycosylation. Complementary mutational studies identified Asn66, Asn75, and Asn90, which are located in extracellular loop 1, as primary targets. Conclusions: Our studies show that SLC17A4 facilitates the transport of T3 and T4, and less efficiently rT3 and 3,3′-T2. Further studies should reveal the physiological role of SLC17A4 in TH regulation.

Original languageEnglish
Pages (from-to)326-335
Number of pages10
JournalThyroid
Volume32
Issue number3
DOIs
Publication statusPublished - Mar 2022

Bibliographical note

Funding Information:
This study was supported by a grant from the European Thyroid Association (to S.G.) and the Netherlands Organisation for Health Research and Development (project number 113303005) (to W.E.V.).

Publisher Copyright:
Copyright © 2022 Mary Ann Liebert, Inc.

Fingerprint

Dive into the research topics of 'Functional Characterization of the Novel and Specific Thyroid Hormone Transporter SLC17A4'. Together they form a unique fingerprint.

Cite this